{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T23:25:27Z","timestamp":1768001127568,"version":"3.49.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Invasive candidiasis is an important cause of sepsis in extremely low birth weight infants (ELBW, &lt; 1000\u2009g), is often fatal, and frequently results in neurodevelopmental impairment (NDI) among survivors. We sought to assess the antifungal minimum inhibitory concentration (MIC) distribution for <jats:italic toggle=\"yes\">Candida<\/jats:italic> in ELBW infants and evaluate the association between antifungal resistance and death or NDI.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This was a secondary analysis of a National Institute of Child Health and Human Development Neonatal Research Network study. MIC values were determined for fluconazole, amphotericin B and micafungin. NDI was assessed at 18\u201322 months adjusted age using the Bayley Scales of Infant Development. An infant was defined as having a resistant <jats:italic toggle=\"yes\">Candida<\/jats:italic> isolate if \u2265 1 positive cultures from normally sterile sites (blood, cerebrospinal fluid, or urine) were resistant to \u2265 1 antifungal agent. In addition to resistance status, we categorized fungal isolates according to MIC values (low and high). The association between death\/NDI and MIC level was determined using logistic regression, controlling for gestational age and Bayley Scales of Infant Development (II or III).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Among 137 ELBW infants with IC, MICs were determined for 308 isolates from 110 (80%) infants. Three <jats:italic toggle=\"yes\">Candida<\/jats:italic> isolates from 3 infants were resistant to fluconazole. None were resistant to amphotericin B or micafungin. No significant difference in death, NDI, or death\/NDI between groups with low and high MICs was observed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Antifungal resistance was rare among infecting <jats:italic toggle=\"yes\">Candida<\/jats:italic> isolates, and MIC level was not associated with increased risk of death or NDI in this cohort of ELBW infants.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000001913","type":"journal-article","created":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T14:17:40Z","timestamp":1516889860000},"page":"923-929","source":"Crossref","is-referenced-by-count":20,"title":["Antifungal Susceptibility and Clinical Outcome in Neonatal Candidiasis"],"prefix":"10.1097","volume":"37","author":[{"given":"Julie","family":"Autmizguine","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Physiology, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, Canada"},{"name":"Department of Pediatrics, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, Canada"},{"name":"Department of Pediatrics, Duke University, Durham, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Tan","sequence":"additional","affiliation":[{"name":"Statistics and Epidemiology Unit, RTI International, Research Triangle Park, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Cohen-Wolkowiez","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Michael","family":"Cotten","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Duke University, Durham, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Wiederhold","sequence":"additional","affiliation":[{"name":"University of Texas Health Science Center at San Antonio, San Antonio, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald N.","family":"Goldberg","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Emory University, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ira","family":"Adams-Chapman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Emory University, Atlanta, GA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara J.","family":"Stoll","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Emory University, Atlanta, GA"},{"name":"Department of Pediatrics, McGovern Medical School at The University of Texas Health Science Center at Houston, Houston, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Brian","family":"Smith","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel K.","family":"Benjamin","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S0378-3782(12)70019-1","article-title":"Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units.","volume":"88","author":"Hornik","year":"2012","journal-title":"Early Hum Dev"},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1542\/peds.110.2.285","article-title":"Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network.","volume":"110","author":"Stoll","year":"2002","journal-title":"Pediatrics"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1542\/peds.2013-0671","article-title":"Changes in the incidence of candidiasis in neonatal intensive care units.","volume":"133","author":"Aliaga","year":"2014","journal-title":"Pediatrics"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1542\/peds.2004-2292","article-title":"Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months.","volume":"117","author":"Benjamin","year":"2006","journal-title":"Pediatrics"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1542\/peds.2005-2677","article-title":"The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants.","volume":"118","author":"Cotten","year":"2006","journal-title":"Pediatrics"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1542\/peds.2007-1130","article-title":"Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species.","volume":"121","author":"Healy","year":"2008","journal-title":"Pediatrics"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1542\/peds.2005-1969","article-title":"Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants.","volume":"117","author":"Uko","year":"2006","journal-title":"Pediatrics"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1001\/jama.2014.2624","article-title":"Effect of fluconazole prophylaxis on candidiasis and mortality in premature infants: a randomized clinical trial.","volume":"311","author":"Benjamin","year":"2014","journal-title":"JAMA"},{"issue":"4","key":"R9-20230912","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jpeds.2013.04.034","article-title":"Neurodevelopmental outcome of extremely low birth weight infants with Candida infection.","volume":"163","author":"Adams-Chapman","year":"2013","journal-title":"J Pediatr"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/0974-2727.59699","article-title":"Emergence of nonalbicans Candida in neonatal septicemia and antifungal susceptibility: experience from a tertiary care center.","volume":"1","author":"Goel","year":"2009","journal-title":"J Lab Physicians"},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.drup.2010.09.002","article-title":"Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods.","volume":"13","author":"Pfaller","year":"2010","journal-title":"Drug Resist Updat"},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1128\/CMR.19.2.435-447.2006","article-title":"Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing.","volume":"19","author":"Pfaller","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1128\/AAC.00569-08","article-title":"Population pharmacokinetics of fluconazole in young infants.","volume":"52","author":"Wade","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"R15-20230912","doi-asserted-by":"crossref","first-page":"e865","DOI":"10.1542\/peds.2009-3412","article-title":"Neonatal candidiasis: epidemiology, risk factors, and clinical judgment.","volume":"126","author":"Benjamin","year":"2010","journal-title":"Pediatrics"},{"key":"R16-20230912","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1086\/313973","article-title":"Candidal meningitis in neonates: a 10-year review.","volume":"31","author":"Fernandez","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R17-20230912","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00006454-200006000-00002","article-title":"Systemic Candida infection in extremely low birth weight infants: short term morbidity and long term neurodevelopmental outcome.","volume":"19","author":"Friedman","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R18-20230912","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-2001-14524","article-title":"Antifungal susceptibility testing and the correlation with clinical outcome in neonatal candidemia.","volume":"18","author":"Huang","year":"2001","journal-title":"Am J Perinatol"},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s101560070006","article-title":"Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?","volume":"6","author":"Kovacicova","year":"2000","journal-title":"J Infect Chemother"},{"key":"R20-20230912","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1128\/AAC.50.4.1287-1292.2006","article-title":"Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome.","volume":"50","author":"Park","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"R21-20230912","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1128\/JCM.00680-13","article-title":"Multicenter study evaluating the Vitek MS system for identification of medically important yeasts.","volume":"51","author":"Westblade","year":"2013","journal-title":"J Clin Microbiol"},{"key":"R22-20230912","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1128\/JCM.06713-11","article-title":"Routine identification of medical fungi by the new Vitek MS matrix-assisted laser desorption ionization-time of flight system with a new time-effective strategy.","volume":"50","author":"Iriart","year":"2012","journal-title":"J Clin Microbiol"},{"key":"R25-20230912","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.drup.2011.01.004","article-title":"Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.","volume":"14","author":"Pfaller","year":"2011","journal-title":"Drug Resist Updat"},{"key":"R26-20230912","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1128\/JCM.05047-11","article-title":"Triazole and echinocandin MIC distributions with epidemiological cutoff values for differentiation of wild-type strains from non-wild-type strains of six uncommon species of Candida.","volume":"49","author":"Pfaller","year":"2011","journal-title":"J Clin Microbiol"},{"key":"R27-20230912","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.diagmicrobio.2013.05.019","article-title":"Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values.","volume":"77","author":"Pfaller","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R29-20230912","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1542\/peds.2008-2055","article-title":"Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients.","volume":"123","author":"Blyth","year":"2009","journal-title":"Pediatrics"},{"key":"R30-20230912","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1439-0507.2012.02189.x","article-title":"Neonatal invasive candidiasis in Tunisian hospital: incidence, risk factors, distribution of species and antifungal susceptibility.","volume":"55","author":"Ben Abdeljelil","year":"2012","journal-title":"Mycoses"},{"key":"R31-20230912","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s10096-004-1210-9","article-title":"Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates.","volume":"23","author":"Roilides","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R32-20230912","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1128\/JCM.05474-11","article-title":"Epidemiology and antifungal susceptibility of bloodstream fungal isolates in pediatric patients: a Spanish multicenter prospective survey.","volume":"49","author":"Pem\u00e1n","year":"2011","journal-title":"J Clin Microbiol"},{"key":"R33-20230912","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa065733","article-title":"A multicenter, randomized trial of prophylactic fluconazole in preterm neonates.","volume":"356","author":"Manzoni","year":"2007","journal-title":"N Engl J Med"},{"key":"R34-20230912","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jpeds.2005.02.020","article-title":"Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants.","volume":"147","author":"Bertini","year":"2005","journal-title":"J Pediatr"},{"key":"R35-20230912","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1056\/NEJMoa010494","article-title":"Fluconazole prophylaxis against fungal colonization and infection in preterm infants.","volume":"345","author":"Kaufman","year":"2001","journal-title":"N Engl J Med"},{"key":"R36-20230912","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1128\/JCM.03044-13","article-title":"Impact of new antifungal breakpoints on antifungal resistance in Candida species.","volume":"52","author":"Fothergill","year":"2014","journal-title":"J Clin Microbiol"},{"key":"R37-20230912","doi-asserted-by":"crossref","first-page":"5590","DOI":"10.1128\/AAC.00466-11","article-title":"Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia.","volume":"55","author":"Cant\u00f3n","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"R38-20230912","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1093\/jac\/dku124","article-title":"Support for the EUCAST and revised CLSI fluconazole clinical breakpoints by Sensititre\u00ae YeastOne\u00ae for Candida albicans: a prospective observational cohort study.","volume":"69","author":"van Hal","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"R39-20230912","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R40-20230912","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/INF.0b013e31819f1f50","article-title":"Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infants.","volume":"28","author":"Wade","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R41-20230912","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/archpediatrics.2010.20","article-title":"Underestimation of developmental delay by the new Bayley-III Scale.","volume":"164","author":"Anderson","year":"2010","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R42-20230912","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/cid\/cir800","article-title":"Outcomes following candiduria in extremely low birth weight infants.","volume":"54","author":"Wynn","year":"2012","journal-title":"Clin Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201809000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:30:09Z","timestamp":1694557809000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201809000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001913","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}